| Full text | |
| Author(s): |
Total Authors: 3
|
| Affiliation: | [1] Sao Paulo Business Sch, Dept Publ Adm, Sao Paulo - Brazil
[2] Inst Educ & Res INSPER, Sao Paulo - Brazil
[3] Minist Hlth, Grad Studies Publ Hlth, Natl Sch Publ Hlth, Fiocruz, Rio De Janeiro - Brazil
Total Affiliations: 3
|
| Document type: | Journal article |
| Source: | DEVELOPMENT IN PRACTICE; v. 29, n. 7 JULY 2019. |
| Web of Science Citations: | 0 |
| Abstract | |
This viewpoint reflects on the challenges of promoting affordable and innovative medicines while fostering a competitive environment for research and development in developing countries. We explore the life sciences industrial policies of Brazil and the United Kingdom in order to identify mechanisms and conditions that could serve as lessons to practitioners in other countries. We suggest three crucial design attributes: a strategic collaboration between a health system and the private sector, coordination and accountability mechanisms, and a network of support (that is, embeddedness). (AU) | |
| FAPESP's process: | 18/06997-0 - Never waste a crisis: pharmaceutical industrial policy in the UK post-Brexit |
| Grantee: | Mariana Ramos Teixeira |
| Support Opportunities: | Scholarships abroad - Research Internship - Scientific Initiation |
| FAPESP's process: | 15/18604-5 - Policies to increase the competitiveness of the pharmaceutical sector: Brazil's experience |
| Grantee: | Elize Massard da Fonseca |
| Support Opportunities: | Research Grants - Young Investigators Grants |